Dr. Hema Ramkumar received her medical degree from the
Northwestern University Feinberg School of Medicine, where she graduated with
honors in research, after receiving dual undergraduate degrees in Developmental
Neurosciences and International Studies from Northwestern University. She
completed her ophthalmology residency at the University of California, San
Diego, where she served as Chief Resident and received the Resident Research
Award. In 2020, she completed her fellowship in uveitis, ocular oncology, and vitreoretinal
surgery at the Shiley Eye Institute and Jacobs Retina Center at UCSD. Her
macular degeneration research has earned recognition through the Howard Hughes
Medical Institute Scholarship and the Thrasher Foundation Early Career Award.
Her prior work focused on omega-3 fatty acid metabolism and retinal imaging
technologies in AMD. She founded
Oculogenex, and her team has been focused on the development of novel treatments
for macular degeneration. She is a principal investigator with the National
Science Foundation and the Center for the Advancement of Science in Space (CASIS).
She led the mission that sent the first gene therapy featured in this
publication to space. She is a practicing retinal surgeon in Fullerton, California, with Retina Consultants of Orange County, where she leads a clinical trial center focused on advancing new therapeutics for retinal
diseases.
Dr. Hema Ramkumar received her medical degree from the
Northwestern University Feinberg School of Medicine, where she graduated with
honors in research, after receiving dual undergraduate degrees in Developmental
Neurosciences and International Studies from Northwestern University. She
completed her ophthalmology residency at the University of California, San
Diego, where she served as Chief Resident and received the Resident Research
Award. In 2020, she completed her fellowship in uveitis, ocular oncology, and vitreoretinal
surgery at the Shiley Eye Institute and Jacobs Retina Center at UCSD. Her
macular degeneration research has earned recognition through the Howard Hughes
Medical Institute Scholarship and the Thrasher Foundation Early Career Award.
Her prior work focused on omega-3 fatty acid metabolism and retinal imaging
technologies in AMD. She founded
Oculogenex, and her team has been focused on the development of novel treatments
for macular degeneration. She is a principal investigator with the National
Science Foundation and the Center for the Advancement of Science in Space (CASIS).
She led the mission that sent the first gene therapy featured in this
publication to space. She is a practicing retinal surgeon in Fullerton, California, with Retina Consultants of Orange County, where she leads a clinical trial center focused on advancing new therapeutics for retinal
diseases.